Cardiff Oncology (CRDF) EBT Margin (2016 - 2025)
Cardiff Oncology (CRDF) has disclosed EBT Margin for 15 consecutive years, with 2969.14% as the latest value for Q4 2025.
- Quarterly EBT Margin rose 483550.0% to 2969.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7732.88% through Dec 2025, down 109663.0% year-over-year, with the annual reading at 7732.88% for FY2025, 108691.0% down from the prior year.
- EBT Margin hit 2969.14% in Q4 2025 for Cardiff Oncology, up from 9381.67% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 2969.14% in Q4 2025 to a low of 14964.86% in Q1 2022.
- Historically, EBT Margin has averaged 8873.0% across 5 years, with a median of 7970.92% in 2021.
- Biggest five-year swings in EBT Margin: soared 963902bps in 2024 and later tumbled -744973bps in 2025.
- Year by year, EBT Margin stood at 7162.41% in 2021, then dropped by -2bps to 7337.5% in 2022, then rose by 19bps to 5976.92% in 2023, then plummeted by -31bps to 7804.64% in 2024, then soared by 62bps to 2969.14% in 2025.
- Business Quant data shows EBT Margin for CRDF at 2969.14% in Q4 2025, 9381.67% in Q3 2025, and 11522.31% in Q2 2025.